These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15364003)

  • 1. Effect of pioglitazone on endotoxin-induced decreases in hepatic drug-metabolizing enzyme activity and expression of CYP3A2 and CYP2C11.
    Ueyama J; Kitaichi K; Nadai M; Iwase M; Tomyo N; Kanazawa H; Suzuki R; Takagi K; Takagi K; Hasegawa T
    Eur J Pharmacol; 2004 Sep; 498(1-3):257-65. PubMed ID: 15364003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters.
    Ueyama J; Nadai M; Kanazawa H; Iwase M; Nakayama H; Hashimoto K; Yokoi T; Baba K; Takagi K; Takagi K; Hasegawa T
    Eur J Pharmacol; 2005 Mar; 510(1-2):127-34. PubMed ID: 15740733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of cytochrome P450 proteins and its activities by Shiga-like toxin II from Escherichia coli O157:H7.
    Kitaichi K; Nakayama H; Ueyama J; Nadai M; Baba K; Takagi K; Takagi K; Ohta M; Hasegawa T
    Biochem Pharmacol; 2004 Apr; 67(8):1427-35. PubMed ID: 15041460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thalidomide on endotoxin-induced decreases in activity and expression of hepatic cytochrome P450 3A2.
    Ueyama J; Nadai M; Zhao YL; Kanazawa H; Takagi K; Kondo T; Takagi K; Wakusawa S; Abe F; Saito H; Miyamoto K; Hasegawa T
    Biol Pharm Bull; 2008 Aug; 31(8):1596-600. PubMed ID: 18670095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of midazolam pharmacokinetics in Wistar rats treated with lipopolysaccharide: relationship between total CYP and CYP3A2.
    Kato R; Yamashita S; Moriguchi J; Nakagawa M; Tsukura Y; Uchida K; Amano F; Hirotani Y; Ijiri Y; Tanaka K
    Innate Immun; 2008 Oct; 14(5):291-7. PubMed ID: 18809653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats.
    Nadai M; Sekido T; Matsuda I; Li W; Kitaichi K; Itoh A; Nabeshima T; Hasegawa T
    J Pharm Pharmacol; 1998 Aug; 50(8):871-9. PubMed ID: 9751451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide.
    Kitaichi K; Wang L; Takagi K; Iwase M; Shibata E; Nadai M; Hasegawa T
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2697-701. PubMed ID: 10543749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection.
    Callahan SM; Wonganan P; Croyle MA
    Virol J; 2008 Sep; 5():111. PubMed ID: 18826641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of hepatic function determined by cytochrome P450-dependent drug metabolism lags after compensatory hepatic volume changes after portal vein ligation in rats.
    Takemura S; Minamiyama Y; Hirohashi K; Kubo S; Funae Y; Kinoshita H
    J Surg Res; 2006 Aug; 134(2):285-91. PubMed ID: 16564546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sodium alterations on hepatic cytochrome P450 3A2 and 2C11 and renal function in rats.
    Liu J; Callahan SM; Brunner LJ
    Drug Dev Ind Pharm; 2003 Aug; 29(7):767-75. PubMed ID: 12906334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tumor necrosis factor-alpha in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin.
    Miyoshi M; Nadai M; Nitta A; Ueyama J; Shimizu A; Takagi K; Nabeshima T; Takagi K; Saito K; Hasegawa T
    Eur J Pharmacol; 2005 Jan; 507(1-3):229-37. PubMed ID: 15659313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of transgene expression on drug metabolism following systemic adenoviral vector administration.
    Callahan SM; Boquet MP; Ming X; Brunner LJ; Croyle MA
    J Gene Med; 2006 May; 8(5):566-76. PubMed ID: 16508909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats.
    Chen J; Robertson G; Field J; Liddle C; Farrell GC
    Hepatology; 1998 Sep; 28(3):624-30. PubMed ID: 9731550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple mechanisms in indomethacin-induced impairment of hepatic cytochrome P450 enzymes in rats.
    Masubuchi Y; Masuda E; Horie T
    Gastroenterology; 2002 Mar; 122(3):774-83. PubMed ID: 11875010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia.
    Takemura S; Minamiyama Y; Imaoka S; Funae Y; Hirohashi K; Inoue M; Kinoshita H
    J Hepatol; 1999 Jun; 30(6):1035-44. PubMed ID: 10406181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AhR and PPARalpha: antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11.
    Shaban Z; Soliman M; El-Shazly S; El-Bohi K; Abdelazeez A; Kehelo K; Kim HS; Muzandu K; Ishizuka M; Kazusaka A; Fujita S
    Xenobiotica; 2005 Jan; 35(1):51-68. PubMed ID: 15788368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dietary zinc deficiency during development on hepatic CYP2C11, CYP2C12, CYP3A2, CYP3A9, and CYP3A18 expression in postpubertal male rats.
    Xu Z; Kawai M; Bandiera SM; Chang TK
    Biochem Pharmacol; 2001 Nov; 62(9):1283-91. PubMed ID: 11705462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
    Chang TK; Chen H; Waxman DJ
    Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethylbenzene induces microsomal oxygen free radical generation: antibody-directed characterization of the responsible cytochrome P450 enzymes.
    Serron SC; Dwivedi N; Backes WL
    Toxicol Appl Pharmacol; 2000 May; 164(3):305-11. PubMed ID: 10799341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of latently expressed CYP2C11, CYP3A2, and growth hormone defects in neonatally monosodium glutamate-treated male rats by the N-methyl-D-aspartate receptor antagonist dizocilpine maleate.
    Kaufhold A; Nigam PK; Dhir RN; Shapiro BH
    J Pharmacol Exp Ther; 2002 Aug; 302(2):490-6. PubMed ID: 12130706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.